Search

everythinglearnresearchcommunity

for

Search:↓

Biotin supplementation during isotretinoin treatment for acne may help maintain skin hydration and improve hair growth.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

The ethosomal formulation improved finasteride delivery through the skin.

Finasteride tablets and capsules work the same in the body.

Applying a specific inhibitor lightens skin and hair color.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

FK506 may stimulate hair growth when applied to the skin.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Sinapic acid may protect skin cells from UV damage and reduce inflammation, making it a promising anti-aging cosmetic ingredient.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Tofacitinib taken by mouth helps treat hair loss in children.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Chaga mushrooms contain compounds that may promote hair growth better than common treatments.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Both amodimethicone and dimethicone copolyol amine are effective hair conditioners.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.